301371 Harbin Fuerjia Technology

Watchlist

24.55
-0.05-0.20%

Market Closed Jun 20 15:00 CST

12.77BMarket Cap21.26P/E (TTM)

About Harbin Fuerjia Technology Company

The company was founded in 2017. It is a company with broad market recognition and brand influence, engaged in R&D, production and sales of professional skin care products. The company closely follows changes in consumer demand, adopts precise marketing strategies, and gradually accumulates brand power and product power through the new consumption dynamics and broad layout of professional channels in the rise of domestic products. The company is engaged in R&D, production and sales of professional skin care products. The company's products are mainly divided into medical device products and functional skin care products.

Company Profile

Short Name-A敷尔佳

Symbol-A301371

Company NameHarbin Fuerjia Technology Co., Ltd.

Listing DateAug 1, 2023

Issue Price55.68

Shares Offered40.08M share(s)

FoundedNov 28, 2017

Legal Representativeliguo zhang

General Managerna sun

Secretarybaijiao deng

Accounting FirmBeijing Dahua International Accounting Firm (Special General Partnership)

Securities Representativehong wu

Legal CounselBeijing Zhonglun (Shenzhen) Law Firm

Employees461

Phone0451-59778888

Office AddressNo. 500 Meigu Road, Songbei District, Harbin

Zip Code150000

Registered AddressNo. 500 Meigu Road, Songbei District, Harbin, Heilongjiang

Fax0451-59778888

Emailfuerjia@voolga.net

Websitehttp://www.voolga.net/

Business License230103101227242

BusinessGeneral projects: medical research and experimental development; second-class medical device sales; first-class medical device production; cosmetics wholesale; cosmetic retail; first-class medical device sales; health food (pre-packaged) sales; personal hygiene products sales; hygiene products and disposable medical supplies sales; daily necessities sales; wholesale of daily necessities; technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; import and export of goods. License projects: Class II medical device production; Class III medical device management; Class III medical device production; food production; food sales; health food production; cosmetics production; road cargo transportation (excluding dangerous goods); tourism development project planning consultation.

Company Executives

Name
Position
Salary

liguo zhang
Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee
619.40K

yanfei liang
Directors, Strategy Committee Members, Audit Committee Members
62.50K

baijiao deng
Directors, Board Secretary, Chief Financial Officer, Strategy Committee Members, Member of the Remuneration and Assessment Committee
762.60K

shuying yao
Independent Directors, Audit Committee Members, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members
62.50K

xiaoxian wang
Independent Directors, Chairman of the Audit Committee, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee
100.00K

hong wu
Securities Affairs Representative
--

xiaoming xu
Chairman of the Supervisory Board, Auditors
318.70K

lidong guo
Auditors
20.00K

na sun
General Manager
1.83M

wei wang
Deputy General Manager
1.32M

li xiao
Deputy General Manager
1.32M

qingzhu hao
Deputy General Manager
1.32M

hongbo zhu
Head of Internal Audit
463.40K

ruonan song
Employee Supervisors
104.40K

The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios. The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios.

No. Symbol 5D % Chg

iPath Series B S&P 500 VIX Short-Term Futures ETN

VXX